Learn more

WELLBEINGHAPPYPHARM CO LTD

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    143,070
  • Filing trend
    ⇩ 100.0%
About

WELLBEINGHAPPYPHARM CO LTD has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets medical technology, pharmaceuticals and macromolecular chemistry and polymers are BEIJING DATSING BIO TECH CO LTD, BEIJING BOHUI RUIJIN BIOLOGICAL SCIENCE & TECH CO LTD and BORCK ALEXANDER.

Patent filings in countries

World map showing WELLBEINGHAPPYPHARM CO LTDs patent filings in countries
# Country Total Patents
#1 Republic of Korea 12

Patent filings per year

Chart showing WELLBEINGHAPPYPHARM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Eom Dong Yeol 10
#2 Park Yong Hoon 7
#3 So Hyeon Suk 6
#4 Yug Gyeong Chang 5
#5 Soh Hyun Sook 5
#6 Gim Eun Hye 4
#7 Kim Eun Hye 3
#8 Choi Seung In 2
#9 Uom Dong Yeol 2
#10 Lee Yong Sung 2

Latest patents

Publication Filing date Title
KR20190023794A A preparing method of tissue repair treatment composition using the two step cross-linking and the composition therefrom
KR20180060537A Whitening functional cosmetic composition having skin-regeneration and moistureizing
KR20180060542A Wound dressing with chitosan hydrogel and pdrn and a dressing therefor
KR20180040812A A compostion with anti-adhesion property
KR20180040811A Prosthesis biomaterial as hyaluronic acid coss-linked by biopolymer including amine and a method thereof
KR20170029977A Solubilizer for hydroxyapatite
KR20170029817A Biocompatible composition containing spacers and method for production thereof
KR20170005265A multilayered coated microparticle for tissue reconstruction and method for production thereof
KR20160130906A the bow-type suture for removing wrinkles.
KR20160130905A the elastic suture for removing wrinkles
KR20150027777A Composite medical materials and manufacturing method using crosslinked hyaluronic acid.
KR20150030682A Hyaluronic acid (HA) inhibitory biomaterials containing anti-inflammatory and anti-blood clotting components